Audubon — Pathologists documented the first death of a loon in New England from avian malaria. Here’s how they got from corpse to diagnosis.
Popular Science — A new test for HPV has been approved as a screen for cervical cancer, but doctors are concerned that it may harm younger women.
Refinery 29 — There are fewer differences between shampoos and conditioners than marketers would have you believe.
The Scientist — Forget stamps: one bioengineer amasses broken artificial joints to learn why they failed and how to build better ones.
The Scientist — Breast implants leaking contaminated silicone are causing a fuss in Europe, but all breast implants carry risks.
The Scientist — Preliminary data from human embryonic stem cell trials for two degenerative eye disorders are promising, but challenges remain for more complex tissues.
Nature Medicine — Combining multiple medicines into a single pill is harder than it sounds.
Nature Medicine — Unrecognizable today, early drug ads were bold, colorful statements for the nascent field of graphic design.
Nature Medicine — Three widely-used artemisinin variants are equally effective at ridding youngsters of the malaria parasite.
Nature Medicine — A burst of research into the genetics of autism has given scientists insight into the basis for the disorder. Now, some companies aim to capitalize on these findings by developing DNA screens that might one day provide a diagnosis at birth.
Nature Medicine — Despite a half century of research into malaria, laboratory models of the disease have changed little — a fact that could be hindering the development of new vaccines.
Nature Medicine — The pharmaceutical industry contributed more than $30 million to political causes during the 2010 election cycle alone.